Cartesian Therapeutics
RNAC
#8958
Rank
C$0.26 B
Marketcap
C$8.80
Share price
4.24%
Change (1 day)
-13.76%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -C$72.61 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are C$1.47 Million. In 2025 the company made an earning of -C$70.28 Million a decrease over its 2024 earnings that were of -C$38.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$72.61 Million3.32%
2025 -C$70.28 Million80.63%
2024 -C$38.91 Million-88.5%
2023 -C$0.34 Billion-724%
2022 C$54.2 M-649.67%
2021 -C$9.87 Million-89.78%
2020 -C$96.54 Million25.06%
2019 -C$77.19 Million-15.68%
2018 -C$91.55 Million-0.43%
2017 -C$91.94 Million83.41%
2016 -C$50.13 Million44.3%
2015 -C$34.74 Million